25-hydroxyvitamin D(3)-1alpha-hydroxylase expression in normal and pathological parathyroid glands.
about
Vitamin D metabolism and action in human bone marrow stromal cells25-Hydroxyvitamin D3 1alpha-hydroxylase expression in breast cancer and use of non-1alpha-hydroxylated vitamin D analogue.Role of vitamin D in diabetes mellitus and chronic kidney diseaseRole of calcium, vitamin D, and the extrarenal vitamin D hydroxylases in carcinogenesisVitamin D metabolism in human bone marrow stromal (mesenchymal stem) cellsVitamin D - effects on skeletal and extraskeletal health and the need for supplementation.Aberrant WNT/β-catenin signaling in parathyroid carcinoma.Increased expression of 25-hydroxyvitamin D-1alpha-hydroxylase in dysgerminomas: a novel form of humoral hypercalcemia of malignancy.Lower vitamin D levels in surgical hyperparathyroidism versus thyroid patients.A plausible role for actin gamma smooth muscle 2 (ACTG2) in small intestinal neuroendocrine tumorigenesisThe interaction effects of aerobic exercise training and vitamin D supplementation on plasma lipid profiles and insulin resistance in ovariectomized rats.A novel CaSR mutation presenting as a severe case of neonatal familial hypocalciuric hypercalcemia.Vitamin D and cancer: clinical aspects.Vitamin D status and outcomes after renal transplantation.Vitamin D and aging: old concepts and new insights.Prolonged treatment with vitamin D in postmenopausal women with primary hyperparathyroidism.Prevalence of 25(OH) vitamin D insufficiency and deficiency in pediatric patients on chronic dialysis.Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study.Analysis of CYP27B1, encoding 25-hydroxyvitamin D-1alpha-hydroxylase, as a candidate tumor suppressor gene in primary and severe secondary/tertiary hyperparathyroidism.Potential for vitamin D receptor agonists in the treatment of cardiovascular disease.Cholecalciferol Additively Reduces Serum Parathyroid Hormone and Increases Vitamin D and Cathelicidin Levels in Paricalcitol-Treated Secondary Hyperparathyroid Hemodialysis Patients.Effects of Cholecalciferol vs Calcifediol on Total and Free 25-Hydroxyvitamin D and Parathyroid Hormone.Effects of High-Dose Vitamin D2 Versus D3 on Total and Free 25-Hydroxyvitamin D and Markers of Calcium Balance.A kidney-specific genetic control module in mice governs endocrine regulation of the cytochrome P450 gene Cyp27b1 essential for vitamin D3 activation.1alpha,25-Dihydroxyvitamin D hydroxylase in adipocytes.Cholecalciferol Additively Reduces Serum Parathyroid Hormone Levels in Severe Secondary Hyperparathyroidism Treated with Calcitriol and Cinacalcet among Hemodialysis Patients.Exploring vitamin D metabolism and function in cancer.Physiologic and pathophysiologic roles of extra renal CYP27b1: Case report and review.Without 1α-hydroxylation, the gene expression profile of 25(OH)D3 treatment overlaps deeply with that of 1,25(OH)2D3 in prostate cancer cells.The Anti-Inflammatory Effects of Vitamin D in Tumorigenesis
P2860
Q24649058-6B56BDAD-74E1-4FDC-93F5-B56779F6A0F2Q25257771-38D31E7A-5C87-46AB-96D1-19C5BE7AD3ECQ26765231-AF658252-4836-4D22-BC05-1BC4B40D1AAEQ27011538-9C117AFC-1F82-457C-8008-E58A548673D4Q27024504-2CA7ACC9-8158-46E8-BDC6-5C7DB72733E2Q30425759-B47EA49A-D350-42F5-8EA1-2A5194303099Q34360642-FAE0C665-6A1F-4614-8B79-4F6D9BB096DAQ35103187-0DCB2AD3-CFDC-4C77-A628-E953E3595394Q35185176-931379DC-6219-4586-8D7A-978E11F46992Q35997446-FFFF8079-9515-4C80-B272-D2D38A4D819DQ36218598-8D91B20E-9BDE-4800-AB6E-74519FB33BC4Q36300239-FB53FF12-F7CF-4397-B33B-373333520468Q36509508-F592F75D-1623-4FF3-8CC6-8B1A40A89C06Q36796584-8CDEEE70-CF19-4CE7-A47E-A4C4DDE86B82Q36832673-C8D74819-386B-49B1-90C0-D07701614A7EQ36925625-209C18AB-226E-4117-AF40-32B7BBD7B196Q37000695-DD682AB8-0439-4872-85EF-0DDEB82B8161Q37125654-5C2B95B9-15EB-4D90-B65D-5BE4B1434AA7Q37209130-D210CCA3-C76E-4509-A5B3-58789FB89A34Q37376932-86518982-44CE-4086-A18C-CFA534BFBBD2Q37463291-268E7553-D6FB-41D5-86A6-3A570DD31BF7Q38758833-80C51635-79BF-4317-8893-F2EFE0700670Q38865661-1A83FA4D-7DCA-4C3A-9424-BED90E63BFB7Q42513663-0F5209EB-282C-4B7F-926A-EB7E90347239Q42807758-09D582D9-4A7A-4642-A262-F73ABAEDE876Q50034239-D1104A50-F9C6-449E-8B04-5656F8D780A6Q52587327-EC5FAF3A-1B0E-4150-A674-7884C3133F6AQ55362990-92933C25-C655-4EAB-8E23-EB8CC7F4E24EQ55468580-FDCBECFB-BB45-4A6C-B35A-C6BB4FDCE63FQ58742403-A5B4A6E3-0564-471C-9FE6-EEBCBCCF945E
P2860
25-hydroxyvitamin D(3)-1alpha-hydroxylase expression in normal and pathological parathyroid glands.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
25-hydroxyvitamin D
@nl
25-hydroxyvitamin D(3)-1alpha- ...... thological parathyroid glands.
@en
type
label
25-hydroxyvitamin D
@nl
25-hydroxyvitamin D(3)-1alpha- ...... thological parathyroid glands.
@en
prefLabel
25-hydroxyvitamin D
@nl
25-hydroxyvitamin D(3)-1alpha- ...... thological parathyroid glands.
@en
P2093
P356
P1476
25-hydroxyvitamin D(3)-1alpha- ...... thological parathyroid glands.
@en
P2093
Gunnar Westin
Göran Akerström
Martin Hewison
Pamela Correa
Per Hellman
Tobias Carling
Ulrika Segersten
P304
P356
10.1210/JCEM.87.6.8604
P407
P577
2002-06-01T00:00:00Z